Microbiological profile of telithromycin, the first ketolide antimicrobial
- 1 January 2001
- journal article
- Published by Elsevier in Clinical Microbiology & Infection
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Macrolide–ketolide inhibition of MLS‐resistant ribosomes is improved by alternative drug interaction with domain II of 23S rRNAMolecular Microbiology, 2000
- Macrolide resistance and erythromycin resistance determinants among Belgian Streptococcus pyogenes and Streptococcus pneumoniae isolatesJournal of Antimicrobial Chemotherapy, 2000
- The Alexander Project 1996–1997: latest susceptibility data from this international study of bacterial pathogens from community-acquired lower respiratory tract infectionsJournal of Antimicrobial Chemotherapy, 2000
- Activity of Telithromycin (HMR 3647) against Anaerobic Bacteria Compared to Those of Eight Other Agents by Time-Kill MethodologyAntimicrobial Agents and Chemotherapy, 1999
- Decreased Susceptibility ofStreptococcus pneumoniaeto Fluoroquinolones in CanadaNew England Journal of Medicine, 1999
- Therapy for pneumococcal infection at the millennium: doubts and certaintiesThe American Journal of Medicine, 1999
- Susceptibilities of Penicillin- and Erythromycin-Susceptible and -Resistant Pneumococci to HMR 3647 (RU 66647), a New Ketolide, Compared with Susceptibilities to 17 Other AgentsAntimicrobial Agents and Chemotherapy, 1998
- mefE is necessary for the erythromycin-resistant M phenotype in Streptococcus pneumoniaeAntimicrobial Agents and Chemotherapy, 1997
- Ketolides lack inducibility properties of MLS(B) resistance phenotypeJournal of Antimicrobial Chemotherapy, 1997
- Bacterial resistance to macrolide, lincosamide, and streptogramin antibiotics by target modificationAntimicrobial Agents and Chemotherapy, 1991